PEDIATRICS Vol. 99 No. 1 January 1997, pp. 23-28

Comparison of Ceftriaxone and Trimethoprim-Sulfamethoxazole for Acute Otitis Media

Received Aug 2, 1995; accepted Feb 21, 1996.

Elizabeth D. Barnett^*, David W. Teele^*, Jerome O. Klein^*, Howard J. Cabral^§, Sigmund J. Kharasch, and the Greater Boston Otitis Media Study Group

From the ^* Maxwell Finland Laboratory for Infectious Diseases and  Pediatric Emergency Department, Boston City Hospital, and ^§ Data Coordinating Center, Boston University School of Public Health, and Boston University School of Medicine, Boston, Massachusetts.

Objective.  The purpose of this prospective, randomized, single-blind trial was to assess the clinical efficacy of a single intramuscular dose of ceftriaxone compared with 10 days of oral trimethoprim-sulfamethoxazole (TMP-SMZ) in treating acute otitis media (AOM).

Methods.  Children aged 3 months through 3 years diagnosed with AOM (signs of acute illness plus evidence of middle-ear effusion) were randomized to treatment with either a single intramuscular dose of ceftriaxone (maximum dose of 50 mg/kg) or 10 days of oral trimethoprim-sulfamethoxazole (8 mg of TMP and 40 mg of SMZ/kg/day in two divided doses). Children were evaluated at scheduled visits on days 3, 14, and 28, and the parents were telephoned on day 5. Children were assessed as cured, improved, or failed on day 3, and as cured or failed on days 14 and 28. Children ill at other times during the study period were, if possible, seen and assessed by the study team.

Results.  Of 596 children enrolled during the study period, 484 were evaluable. Characteristics of evaluable subjects did not differ significantly by drug. On day 3, 223/241 children in the ceftriaxone group (92.5%) and 231/243 (95.1%) in the TMP-SMZ group were cured or improved. On day 14, 158/197 (80.2%) in the ceftriaxone group and 174/212 (82.1%) in the TMP-SMZ group were cured. On day 28, 108/136 (79.4%) in the ceftriaxone group and 124/155 (80%) in the TMP-SMZ group were cured. Persistence of middle-ear fluid did not differ between groups at day 14 (55% in the ceftriaxone group vs 47% in the TMP-SMZ group; P = .16) or at day 28 (39% vs 43%; P = .48). Pain at the injection site persisting at day 3 occurred in 8.4% of children receiving ceftriaxone. New diarrhea was more common in the ceftriaxone group (23.6% vs 9.2%; P < .001).

Conclusion.  A single intramuscular dose of ceftriaxone is comparable in clinical efficacy to 10 days of oral TMP-SMZ for treatment of AOM.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. M. Chandler, S. M. S. Garcia, and D. P. McCormick Consistency of Diagnostic Criteria for Acute Otitis Media: A Review of the Recent Literature Clinical Pediatrics, March 1, 2007; 46(2): 99 - 108. [Abstract] [PDF]

				H. Bauchner and R. E. Besser Promoting the Appropriate Use of Oral Antibiotics: There Is Some Very Good News Pediatrics, March 1, 2003; 111(3): 668 - 670. [Full Text] [PDF]

				J. P.A. Ioannidis, D. G. Contopoulos-Ioannidis, P. Chew, and J. Lau Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections J. Antimicrob. Chemother., November 1, 2001; 48(5): 677 - 689. [Abstract] [Full Text] [PDF]

				G. S. Takata, L. S. Chan, P. Shekelle, S. C. Morton, W. Mason, and S. M. Marcy Evidence Assessment of Management of Acute Otitis Media: I. The Role of Antibiotics in Treatment of Uncomplicated Acute Otitis Media Pediatrics, August 1, 2001; 108(2): 239 - 247. [Abstract] [Full Text] [PDF]

				K. Nagai, T. A. Davies, B. E. Dewasse, G. A. Pankuch, M. R. Jacobs, and P. C. Appelbaum In vitro development of resistance to ceftriaxone, cefprozil and azithromycin in Streptococcus pneumoniae J. Antimicrob. Chemother., December 1, 2000; 46(6): 909 - 915. [Abstract] [Full Text] [PDF]

				P. Gehanno, L. Nguyen, B. Barry, M. Derriennic, F. Pichon, J. M. Goehrs, and P. Berche Eradication by Ceftriaxone of Streptococcus pneumoniae Isolates with Increased Resistance to Penicillin in Cases of Acute Otitis Media Antimicrob. Agents Chemother., January 1, 1999; 43(1): 16 - 20. [Abstract] [Full Text]

				S. L. Kaplan and E. O. Mason Jr. Management of Infections Due to Antibiotic-Resistant Streptococcus pneumoniae Clin. Microbiol. Rev., October 1, 1998; 11(4): 628 - 644. [Abstract] [Full Text] [PDF]

				A. L. Kozyrskyj, G. E. Hildes-Ripstein, S. E. A. Longstaffe, J. L. Wincott, D. S. Sitar, T. P. Klassen, and M. E. K. Moffatt Treatment of Acute Otitis Media With a Shortened Course of Antibiotics: A Meta-analysis JAMA, June 3, 1998; 279(21): 1736 - 1742. [Abstract] [Full Text] [PDF]

				S. F. Dowell, S. M. Marcy, W. R. Phillips, M. A. Gerber, and B. Schwartz Otitis Media---Principles of Judicious Use of Antimicrobial Agents Pediatrics, January 1, 1998; 101(1): 165 - 171. [Abstract] [Full Text] [PDF]

				J. L. Paradise Short-Course Antimicrobial Treatment for Acute Otitis Media: Not Best for Infants and Young Children JAMA, November 26, 1997; 278(20): 1640 - 1642. [Abstract] [PDF]

				S. C. Eppes, J. D. Klein, L. L. Lewis;, E. I. Cantekin;, E. D. Barnett, D. W. Teele, J. O. Klein, and S. J. Kharasch Ceftriaxone for Acute Otitis Media Pediatrics, July 1, 1997; 100(1): 157 - 157. [Full Text] [PDF]

				MORE EVIDENCE SUPPORTING A SINGLE SHOT OF CEFTRIAXONE FOR AOM Journal Watch (General), January 28, 1997; 1997(128): 1 - 1. [Full Text]